Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 113.70
-3.70 (-3.15%)
At close: Sep 4, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 62.3 billion as of September 4, 2026. Its market cap has increased by 127.72% in one year.
Market Cap
62.30B
Enterprise Value
63.47B
Revenue
19.51B
Ranking
n/a
PE Ratio
44.58
Stock Price
113.70
ChartMarket Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 62.30B, an increase of 619.59%. That is a compound annual growth rate of 7.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 62.30B | 176.84% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 146.31B |
| Viyash Scientific | 115.84B |
| Procter & Gamble Health | 93.92B |
| Sanofi India | 72.55B |
| Bliss GVS Pharma | 71.07B |
| FDC Limited | 55.79B |
| Gufic Biosciences | 44.67B |
| Novartis India | 40.42B |